It is interesting that you raise this pilko3. Some less than astute observers might jump to the wrong conclusion of so what. Obviously Ropren is important at this stage of development but the power of Bio A should not be underestimated in any circumstances. While it is early days yet I am very pleased to hear that your sources indicate sales to be going well. It is my belief that Bio A could be huge, and that sales will continue to grow and grow. Remember the manufacturing process for Bio A is not as intensive as for Ropren and so profits are likely to be higher from Bio A than Ropren if Bio A sales get near Ropren in the longer term. Bio A, not to be under estimated!!
Barret
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $11.88M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 22.0¢ | 17.5¢ | $197.3K | 993.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92135 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 39754 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| SLA (ASX) Chart |